Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 31
Love0

Regulatory Landscape of Regenerative Dermatology: Current Frameworks and Future

By Chuck Lin No Comments
INTRODUCTIONStandards in wellness and aesthetics have evolved over time, yet the desire to preserve youthful skin remains a universal priority shaped by biological and evolutionary factors.1 Regenerative dermatology is an…
Read More
Dec 31
Love0

Evaluation of an Advanced, Multimodal Skin Tone Correcting Serum in Participants With Mild-to-Severe Dyschromia and Hyperpigmentation

By Chuck Lin No Comments
INTRODUCTIONMelanin provides pigmentation to skin, hair, and eyes and protects epidermal cells by absorbing harmful ultraviolet (UV) rays. Hyperpigmentation results from excess, cumulative melanin triggered by extrinsic aggressors such as…
Read More
Dec 31
Love0

Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists: A FAERS Database Analysis From 2018-2024

By Chuck Lin No Comments
INTRODUCTIONGlucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are a class of medications that have been widely used for the control of Type 2 Diabetes Mellitus (T2DM).1 A GLP-1 RA stimulates insulin…
Read More
Dec 31
Love0

Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants

By Chuck Lin No Comments
INTRODUCTIONOnychomycosis, a chronic fungal infection of the nail plate or bed, affects up to 14% of individuals in North America and is the most commonly diagnosed nail disorder in the…
Read More
Dec 31
Love0

Characterizing Safety Outcomes of a Dermal Filler: Injection Site and Timing Insights from the Maude Database

By Chuck Lin No Comments
INTRODUCTIONThe number of aesthetic procedures performed has risen sharply in recent years, increasing 14% from 2019 through 2022. This change is primarily due to a 23% increase in non-surgical aesthetic…
Read More
Dec 31
Love0

A Novel Topical Agent for the Management of Hyperpigmentation, Including Melasma and Age Spots

By Chuck Lin No Comments
INTRODUCTIONMelasma is a chronic hyperpigmentation disorder that affects approximately 1% of the general population and up to 1 in 2.5 people in high-risk groups and poses a major therapeutic challenge…
Read More
Dec 29
Love0

Clinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation

By Chuck Lin No Comments
INTRODUCTIONPigmentary disorders (particularly melasma, postinflammatory hyperpigmentation, and solar lentigines) are among the most common skin disorders, impacting patient quality of life, perception by others, and even self-perception.1,2 Hyperpigmentation results from…
Read More
Dec 29
Love0

Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD) is a chronic, systemic disease that impacts individuals of all ages, races, and ethnicities worldwide. It is strongly influenced by genetic, socioeconomic, and environmental factors and is…
Read More
Dec 27
Love0

From Misdiagnosis to Resistance: The Need for Antifungal Stewardship in Dermatology

By Chuck Lin No Comments
INTRODUCTIONDermatophytoses, fungal infections of the skin, hair, and nails, affect approximately 25% of the global population, and reports of antifungal therapy-resistant infections have risen over the past decade.1 A major…
Read More
Dec 27
Love0

Unveiling Artificial Intelligence’s Diagnostic Power and Challenges in Dermatology for Skin of Color: A Review

By Chuck Lin No Comments
INTRODUCTIONArtificial intelligence (AI) has the ability to revolutionize the diagnostic outcomes and accessibility of dermatology.¹ This study scrutinizes the application of AI in dermatology, specifically assessing its effectiveness in diagnosing…
Read More
Dec 27
Love0

Illuminating LiDAR Use in Dermatologic Surgery: A Pilot Survey Exploring New Dimensions in Procedural Care

By Chuck Lin No Comments
INTRODUCTIONPhotography is essential in dermatology for longitudinal comparisons and referrals. While advancements in cameras and mobile phones/tablets have increased technology accessibility, these modalities are limited to two-dimensional (2D) imaging.1 Current…
Read More
Dec 27
Love0

A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma

By Chuck Lin No Comments
INTRODUCTIONMelasma is a chronic condition characterized by often symmetrical areas of hyperpigmentation affecting the cheeks, nose, chin, and forehead. Genetics, hormonal influences, ultraviolet, and visible light exposure are significant contributing…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Skin Improvements in Acne Vulgaris Patients Using Gel-Matrix Moisturizer as a Complement to Topical Treatments January 30, 2026
  • JDD Re:View With Dr. Beer January 29, 2026
  • Racial Disparities in United States Clinical Trial Enrollment for Mycosis Fungoides and Sézary Syndrome January 28, 2026
  • Dual IL-17A/F Blockade for Acrodermatitis Continua of Hallopeau: A Clinical Response to Bimekizumab January 26, 2026
  • Oncoderm Resource Center January 23, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search